Secretory phospholipase A2 as a tumor specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids
No === The use of many common clinically relevant chemotherapeutics is often limited due to insufficient delivery to the tumor and dose-limiting systemic toxicities. Therefore, therapeutics that specifically target tumor cells and are nontoxic to normal cells are required. Here, we report the develo...
| Main Authors: | , , , |
|---|---|
| Language: | en |
| Published: |
2009
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10454/4108 |